Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rolland, Morgane"'
Autor:
Mothe Beatriz, Llano Anuska, Ibarrondo Javier, Daniels Marcus, Miranda Cristina, Zamarreño Jennifer, Bach Vanessa, Zuniga Rosario, Pérez-Álvarez Susana, Berger Christoph T, Puertas Maria C, Martinez-Picado Javier, Rolland Morgane, Farfan Marilu, Szinger James J, Hildebrand William H, Yang Otto O, Sanchez-Merino Victor, Brumme Chanson J, Brumme Zabrina L, Heckerman David, Allen Todd M, Mullins James I, Gómez Guadalupe, Goulder Philip J, Walker Bruce D, Gatell Jose M, Clotet Bonaventura, Korber Bette T, Sanchez Jorge, Brander Christian
Publikováno v:
Journal of Translational Medicine, Vol 9, Iss 1, p 208 (2011)
Abstract Background The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction of responses with the most potent antiviral activity and broad HLA class I restriction. However, current HIV vaccine designs are largely base
Externí odkaz:
https://doaj.org/article/3337f1beb41f4407a507f60ac4570498
Autor:
Kulkarni, Viraj, Valentin, Antonio, Rosati, Margherita, Alicea, Candido, Singh, Ashish K., Jalah, Rashmi, Broderick, Kate E., Sardesai, Niranjan Y., Le Gall, Sylvie, Mothe, Beatriz, Brander, Christian, Rolland, Morgane, Mullins, James I., Pavlakis, George N., Felber, Barbara K.
Publikováno v:
PLoS ONE; Jan2014, Vol. 9 Issue 1, p1-13, 13p
Autor:
Manocheewa, Siriphan, Swain, J. Victor, Lanxon-Cookson, Erinn, Rolland, Morgane, Mullins, James I.
Publikováno v:
PLoS ONE; Jun2013, Vol. 8 Issue 6, p1-10, 10p
HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice.
Autor:
Kulkarni, Viraj, Rosati, Margherita, Valentin, Antonio, Ganneru, Brunda, Singh, Ashish K., Yan, Jian, Rolland, Morgane, Alicea, Candido, Beach, Rachel Kelly, Zhang, Gen-Mu, Le Gall, Sylvie, Broderick, Kate E., Sardesai, Niranjan Y., Heckerman, David, Mothe, Beatriz, Brander, Christian, Weiner, David B., Mullins, James I., Pavlakis, George N., Felber, Barbara K.
Publikováno v:
PLoS ONE; Mar2013, Vol. 8 Issue 3, p1-13, 13p
Autor:
DeCamp, Allan C., Rolland, Morgane, Edlefsen, Paul T., Sanders-Buell, Eric, Hall, Breana, Magaret, Craig A., Fiore-Gartland, Andrew J., Juraska, Michal, Carpp, Lindsay N., Karuna, Shelly T., Bose, Meera, LePore, Steven, Miller, Shana, O’Sullivan, Annemarie, Poltavee, Kultida, Bai, Hongjun, Dommaraju, Kalpana, Zhao, Hong, Wong, Kim, Chen, Lennie, Ahmed, Hasan, Goodman, Derrick, Tay, Matthew Z., Gottardo, Raphael, Koup, Richard A., Bailer, Robert, Mascola, John R., Graham, Barney S., Roederer, Mario, O’Connell, Robert J., Michael, Nelson L., Robb, Merlin L., Adams, Elizabeth, D’Souza, Patricia, Kublin, James G., Corey, Lawrence, Geraghty, Daniel E., Frahm, Nicole, Tomaras, Georgia D., McElrath, M. Juliana, Frenke, Lisa, Styrchak, Sheila, Tovanabutra, Sodsai, Sobieszczyk, Magdalena, Hammer, Scott M., Kim, Jerome H., Mullins, James I., Gilbert, Peter B.
Although the HVTN 505 DNA/recombinant adenovirus type 5 vector HIV-1 vaccine trial showed no overall efficacy, analysis of breakthrough HIV-1 sequences in participants can help determine whether vaccine-induced immune responses impacted viruses that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adebc61222aedb3dbbff3d02db9982df